XRP price could surge as derivatives trading and CBDCs grow. Ripple’s escrow system limits supply, potentially driving higher price volatility. CBDCs’ rise strengthensXRP price could surge as derivatives trading and CBDCs grow. Ripple’s escrow system limits supply, potentially driving higher price volatility. CBDCs’ rise strengthens

Jake Claver: XRP Price Has Enough Room For Major Upside If This Happens

  • XRP price could surge as derivatives trading and CBDCs grow.
  • Ripple’s escrow system limits supply, potentially driving higher price volatility.
  • CBDCs’ rise strengthens XRP’s role in fast, cross-border settlements.

A recent post by market analyst Jake Claver, shared on X, has renewed attention on XRP and its potential for significant price movement. His commentary focused on the market forces and structural dynamics that could shape XRP’s future price trajectory, particularly as derivatives trading grows and the demand for fast cross-border settlement increases.


Claver explained how XRP’s unique position could lead to substantial upside, especially if certain conditions unfold in the market.


XRP’s Price Undervalued as Derivatives Market Expands

In his post, Jake Claver highlighted that XRP’s price is still significantly undervalued, especially when considering the potential rise in derivatives trading. Claver pointed out that with over $6.5 trillion circulating through the foreign exchange markets daily, there is plenty of room for XRP to capture a larger share of this flow.


The increasing adoption of derivatives, which are financial instruments used for speculation and hedging, could have a substantial impact on XRP’s demand and price. As derivative markets expand, more institutional players may look to XRP as a key player for fast settlement, thus driving its value upwards.


CBDCs and Ripple’s Role in the Future of Cross-Border Settlements

Another key factor Claver identified in his analysis is the steady progress of Central Bank Digital Currencies (CBDCs). According to Claver, CBDCs are advancing more quickly than many realize, with numerous major economies already testing digital currencies.


Also Read:  Ethereum Reclaims Crucial 200 EMA as Price Action Signals Trend Shift


In this evolving landscape, Claver notes that the demand for fast, efficient cross-border settlement will continue to rise, and XRP is uniquely positioned to meet that demand. Ripple’s network, with its low-cost and high-speed capabilities, fits perfectly into the future world of digital currencies, especially as CBDCs roll out and require a secure and scalable method for global transactions.


Ripple’s Escrow Model and Its Impact on Price Dynamics

Another key observation Claver made is the impact of Ripple’s escrow system on XRP’s supply and price. Ripple’s escrow releases are time-locked to fixed monthly maximums, which means XRP cannot quickly flood the market with additional supply in times of crisis. This design prevents the emergency dumping of tokens during market disruptions but also results in higher scarcity during periods of increased demand.


While the controlled release is beneficial for maintaining supply predictability, it can make price shocks more severe, as the limited availability of XRP could intensify the effects of any supply-demand imbalances.


Claver’s analysis suggests that while this design could create short-term volatility, it also supports the long-term value of XRP by preventing excessive dilution during periods of growth. As demand for XRP rises with the increased use of derivatives and CBDCs, the constrained supply could lead to significant price appreciation.


The Road Ahead for XRP: Major Upside Potential

Claver’s insights point to a future where XRP’s price could see substantial upside, driven by both derivatives trading and the global shift toward digital currencies. As more financial institutions look for fast, low-cost ways to settle transactions across borders, XRP’s ability to meet these needs could see it become an increasingly important asset in global finance.


Combined with its controlled supply structure, XRP appears poised for significant long-term growth, assuming the conditions Claver has outlined come to fruition.


The growing interest in derivatives and CBDCs, paired with Ripple’s unique escrow model, sets the stage for a potential price surge that could reshape XRP’s position in the broader digital asset market.


Also Read: Ripple (XRP) Long-Term Growth: Here Are Key Developments Already Unfolding


The post Jake Claver: XRP Price Has Enough Room For Major Upside If This Happens appeared first on 36Crypto.

Market Opportunity
XRP Logo
XRP Price(XRP)
$2.0683
$2.0683$2.0683
-1.34%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale

BullZilla, World Liberty Financial, MoonBull, La Culex, and Polkadot (DOT) are taking the spotlight among emerging and established crypto projects […] The post 5 High-Growth Cryptos for 2025: BullZilla Tops the Charts as the Best 100x Crypto Presale appeared first on Coindoo.
Share
Coindoo2025/10/18 08:15
Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26